Michio Hirano, MD
Professor of Neurology
American Board of Psychiatry and Neurology (Neurology and Neuromuscular Medicine)
Insurance: Aetna, Affinity, Amerigroup, CIGNA, Empire BC/BS, HealthPlus, HIP, Oxford, United Healthcare, 1199, Medicare, Medicaid
*Please verify insurance participation with the physician's office when making an appointment.
» The Merritt Center Laboratory of Molecular Neurogenetics
» ALS and Neuromuscular Disorders
» Department of Neurology
» Recent Publications
Dr. Hirano received his B.A. from Harvard College and M.D. from the Albert Einstein College of Medicine. At the Columbia University Medical Center (CUMC), he did his neurology residency training and a post-doctoral fellowship in neuromuscular genetics under Drs. Salvatore DiMauro and Eric Schon.
Currently, Dr. Hirano serves as Co-Director of the CUMC Muscular Dystrophy Association clinic where he sees patients with myopathies and other neuromuscular disorders. He is Director of the H. Houston Merritt Center for Muscular Dystrophy and Related Diseases. Dr. Hirano is studying mitochondrial disorders, including mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) and CoQ10 deficiencies. He is also studying myopathies caused by mtuations in the FHL1 gene.
He is participating in the clinical trial of idebenone for MELAS patients. Together with Co-Principal Investigators, Drs. Salvatore DiMauro and J.L.P (Seamus) Thompson, Dr. Hirano is co-directing the North American Mitochondrial Disease Consortium (NAMDC). Dr. Hirano serves on the NIH Therapeutic Approaches to Genetic Diseases (TAG) study section, Medical Advisory Committee (MAC) of the Muscular Dystrophy Association, and Scientific Advisory Board of the United Mitochondrial Disease Foundation.
» Diagnostic Services for Mitochondrial Disorders and Metabolic Myopathies